Union Hospital,Tongji Medical College,Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Location status: Recruiting
NCT Number: NCT06500312
This is the prospective, observational cohort study (Radiogenomics-Lung), which aims to explore the relationship between the imaging information of lung cancer patients, tumor microenvironment and the prognosis of lung cancer patients.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Wuhan, Hubei, 430000, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 0.5 year
Conducting correlation analysis between body composition and results of multi-omics sequencing
Time frame: 0.5 year
Conducting correlation analysis between radiomic features and results of multi-omics sequencing
Time frame: 2 years
Constructing radiomic model to predict tumor microenvironment. The indicator is the area under the curve (AUC) of the prediction model
Time frame: 3 years
A high-dimensional model was constructed to predict the prognosis of patients through multi-omics sequencing data, body composition, and tumor radiomic features. The indicator is the area under the curve (AUC) of the prediction model.
Contact information is provided by the study sponsor or research team.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Other
Assessment the Association of Imaging and Tumor Microenvironment in Lung Cancer With Radiogenomics
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06424327
Lung Cancer, Lung Cancer Stage I
Tucson, Arizona, United States
View Trial DetailsNCT00001823
Bladder Cancer, Colonic Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00034216
Breast Cancer, Breast Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05401110
Bronchial Neoplasms, Carcinoma, Bronchogenic
Beverly Hills, California, United States
View Trial Details